Synopsys, Inc. (NASDAQ:SNPS - Get Free Report)'s stock price reached a new 52-week low during trading on Monday . The stock traded as low as $442.95 and last traded at $443.05, with a volume of 1475941 shares changing hands. The stock had previously closed at $457.28.
Analysts Set New Price Targets
Several analysts have issued reports on SNPS shares. Wells Fargo & Company decreased their price target on shares of Synopsys from $540.00 to $520.00 and set an "equal weight" rating on the stock in a research report on Thursday, February 27th. Morgan Stanley decreased their target price on Synopsys from $625.00 to $590.00 and set an "overweight" rating on the stock in a research report on Monday, February 24th. Robert W. Baird cut their price target on Synopsys from $644.00 to $630.00 and set an "outperform" rating for the company in a report on Thursday, December 5th. Piper Sandler decreased their price objective on Synopsys from $655.00 to $653.00 and set an "overweight" rating on the stock in a report on Thursday, February 27th. Finally, Loop Capital began coverage on Synopsys in a research report on Monday, November 11th. They set a "buy" rating and a $675.00 price objective on the stock. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $638.58.
Get Our Latest Stock Analysis on Synopsys
Synopsys Price Performance
The stock has a market capitalization of $69.72 billion, a price-to-earnings ratio of 31.05, a price-to-earnings-growth ratio of 3.23 and a beta of 1.16. The firm has a 50 day simple moving average of $502.01 and a 200-day simple moving average of $513.09.
Insider Transactions at Synopsys
In other news, CRO Richard S. Mahoney sold 20,838 shares of the business's stock in a transaction that occurred on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total value of $10,544,236.38. Following the transaction, the executive now directly owns 1,460 shares of the company's stock, valued at $738,774.60. The trade was a 93.45 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $463.75, for a total value of $5,270,982.50. Following the sale, the chief executive officer now owns 70,922 shares in the company, valued at approximately $32,890,077.50. This trade represents a 13.81 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.62% of the stock is owned by insiders.
Hedge Funds Weigh In On Synopsys
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Impax Asset Management Group plc lifted its position in Synopsys by 120.2% during the 3rd quarter. Impax Asset Management Group plc now owns 490,723 shares of the semiconductor company's stock worth $248,497,000 after buying an additional 267,836 shares in the last quarter. United Advisor Group LLC bought a new position in shares of Synopsys in the third quarter worth about $211,000. Catalina Capital Group LLC lifted its position in shares of Synopsys by 4.0% during the third quarter. Catalina Capital Group LLC now owns 779 shares of the semiconductor company's stock worth $394,000 after purchasing an additional 30 shares in the last quarter. Concurrent Investment Advisors LLC grew its stake in shares of Synopsys by 115.5% during the third quarter. Concurrent Investment Advisors LLC now owns 929 shares of the semiconductor company's stock valued at $471,000 after purchasing an additional 498 shares during the last quarter. Finally, M&G PLC grew its stake in shares of Synopsys by 9.0% during the third quarter. M&G PLC now owns 3,213 shares of the semiconductor company's stock valued at $1,626,000 after purchasing an additional 266 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company's stock.
Synopsys Company Profile
(
Get Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Articles
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.